Long-term survival in a patient with primary refractory AML after salvage allogeneic hematopoietic transplantation and post-transplant localized irradiation and venetoclax maintenance: a case report

Long-term survival in a patient with primary refractory AML after salvage allogeneic hematopoietic transplantation and post-transplant localized irradiation and venetoclax maintenance: a case report

For patients with primary refractory AML, allogeneic hematopoietic cell transplantation (allo-HCT) is considered the only curative approach. However, the therapeutic efficacy of salvage transplantation in the non-remission (NR) state remains controversial. We present a patient with primary refractor...

Full description

Bibliographic Details
Main Authors: Yili Fan, Luyao Wang, Boxiao Chen, Jiawei Zhang, Luyu Yang, Xi Qiu, Huawei Jiang, Lei Zhu, Chao Wang, Yang Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Oncology
Subjects:
primary refractory acute myeloid leukemia
allogeneic hematopoietic cell transplantation
relapse
radiotherapy
graft versus leukemia
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1329858/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1329858/full

Similar Items